Latest Stem Cells news
Survival Increase Seen for Adults With Relapsed Ph+ ALL
posted January 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Livtencity for Posttransplant Cytomegalovirus
posted November 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASH Issues Guideline on the Use of HSCT for Sickle Cell Disease
posted September 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Ruxolitinib Best for Glucocorticoid-Refractory, -Dependent GVHD
posted July 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
Stem Cell Treatment Feasible for Aniridia-Related Keratopathy 
Patient Education Increases Skin Cancer Screening in Stem Cell Transplant Survivors 
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma 
Definition of Functional High-Risk Multiple Myeloma Updated in Era of Combo Therapy Monthly Specialist Briefings
Stay Connected
